| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Evan C Rosenberg, Pabitra H Patra, Benjamin J Whalle. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection. Epilepsy & behavior : E&B. vol 70. issue Pt B. 2018-01-16. PMID:28190698. |
in particular, sources as old as the 11th and 15th centuries claimed efficacy for crude marijuana extracts in the treatment of convulsive disorders, prompting a particularly active area of preclinical research into the therapeutic potential of plant cannabinoids in epilepsy. |
2018-01-16 |
2023-08-13 |
Not clear |
| Suman Chandra, Hemant Lata, Mahmoud A ElSohly, Larry A Walker, David Potte. Cannabis cultivation: Methodological issues for obtaining medical-grade product. Epilepsy & behavior : E&B. vol 70. issue Pt B. 2018-01-16. PMID:28202406. |
as studies continue to reveal favorable findings for the use of cannabidiol in the management of childhood epilepsy syndromes and other disorders, best practices for the large-scale production of cannabis are needed for timely product development and research purposes. |
2018-01-16 |
2023-08-13 |
Not clear |
| Suman Chandra, Hemant Lata, Mahmoud A ElSohly, Larry A Walker, David Potte. Cannabis cultivation: Methodological issues for obtaining medical-grade product. Epilepsy & behavior : E&B. vol 70. issue Pt B. 2018-01-16. PMID:28202406. |
such practices have yielded desirable outcomes in cannabis breeding and production: gw pharmaceuticals has a collection of chemotypes dominant in any one of eight cannabinoids, two of which-cannabidiol and cannabidivarin-are supporting epilepsy clinical trial research, whereas in addition to a germplasm bank of high-thc, high-cbd, and intermediate type cannabis varieties, the team at university of mississippi has established an in vitro propagation protocol for cannabis with no detectable variations in morphologic, physiologic, biochemical, and genetic profiles as compared to the mother plants. |
2018-01-16 |
2023-08-13 |
Not clear |
| Magdalena Szaflarski, Barbara Hansen, E Martina Bebin, Jerzy P Szaflarsk. Social correlates of health status, quality of life, and mood states in patients treated with cannabidiol for epilepsy. Epilepsy & behavior : E&B. vol 70. issue Pt B. 2018-01-16. PMID:28236578. |
social correlates of health status, quality of life, and mood states in patients treated with cannabidiol for epilepsy. |
2018-01-16 |
2023-08-13 |
Not clear |
| Magdalena Szaflarski, Barbara Hansen, E Martina Bebin, Jerzy P Szaflarsk. Social correlates of health status, quality of life, and mood states in patients treated with cannabidiol for epilepsy. Epilepsy & behavior : E&B. vol 70. issue Pt B. 2018-01-16. PMID:28236578. |
social characteristics, such as socioeconomic status and race/ethnicity, play a role in the treatment and outcomes of patients with epilepsy (pwe), but little is known about how these factors affect patients receiving cannabidiol (cbd) to treat seizures. |
2018-01-16 |
2023-08-13 |
Not clear |
| Anastasia S Suraev, Lisa Todd, Michael T Bowen, David J Allsop, Iain S McGregor, Carol Ireland, Nicholas Lintzeri. An Australian nationwide survey on medicinal cannabis use for epilepsy: History of antiepileptic drug treatment predicts medicinal cannabis use. Epilepsy & behavior : E&B. vol 70. issue Pt B. 2018-01-16. PMID:28238865. |
an australian nationwide survey on medicinal cannabis use for epilepsy: history of antiepileptic drug treatment predicts medicinal cannabis use. |
2018-01-16 |
2023-08-13 |
Not clear |
| Anastasia S Suraev, Lisa Todd, Michael T Bowen, David J Allsop, Iain S McGregor, Carol Ireland, Nicholas Lintzeri. An Australian nationwide survey on medicinal cannabis use for epilepsy: History of antiepileptic drug treatment predicts medicinal cannabis use. Epilepsy & behavior : E&B. vol 70. issue Pt B. 2018-01-16. PMID:28238865. |
the survey consisted of 39 questions assessing demographics, clinical factors, including diagnosis and seizure types, and experiences with and opinions towards cannabis use in epilepsy. |
2018-01-16 |
2023-08-13 |
Not clear |
| Anastasia S Suraev, Lisa Todd, Michael T Bowen, David J Allsop, Iain S McGregor, Carol Ireland, Nicholas Lintzeri. An Australian nationwide survey on medicinal cannabis use for epilepsy: History of antiepileptic drug treatment predicts medicinal cannabis use. Epilepsy & behavior : E&B. vol 70. issue Pt B. 2018-01-16. PMID:28238865. |
results show that 15% of adults with epilepsy and 13% of parents/guardians of children with epilepsy were currently using, or had previously used, cannabis products to treat epilepsy. |
2018-01-16 |
2023-08-13 |
Not clear |
| Anastasia S Suraev, Lisa Todd, Michael T Bowen, David J Allsop, Iain S McGregor, Carol Ireland, Nicholas Lintzeri. An Australian nationwide survey on medicinal cannabis use for epilepsy: History of antiepileptic drug treatment predicts medicinal cannabis use. Epilepsy & behavior : E&B. vol 70. issue Pt B. 2018-01-16. PMID:28238865. |
the main reasons for medicinal cannabis use were to manage treatment-resistant epilepsy and to obtain a more favorable side-effect profile compared to standard antiepileptic drugs. |
2018-01-16 |
2023-08-13 |
Not clear |
| Anastasia S Suraev, Lisa Todd, Michael T Bowen, David J Allsop, Iain S McGregor, Carol Ireland, Nicholas Lintzeri. An Australian nationwide survey on medicinal cannabis use for epilepsy: History of antiepileptic drug treatment predicts medicinal cannabis use. Epilepsy & behavior : E&B. vol 70. issue Pt B. 2018-01-16. PMID:28238865. |
the number of past antiepileptic drugs tried was a significant predictor of medicinal cannabis use in both adults and children with epilepsy. |
2018-01-16 |
2023-08-13 |
Not clear |
| Anastasia S Suraev, Lisa Todd, Michael T Bowen, David J Allsop, Iain S McGregor, Carol Ireland, Nicholas Lintzeri. An Australian nationwide survey on medicinal cannabis use for epilepsy: History of antiepileptic drug treatment predicts medicinal cannabis use. Epilepsy & behavior : E&B. vol 70. issue Pt B. 2018-01-16. PMID:28238865. |
this survey provides insight into the use of cannabis products for epilepsy, in particular some of the likely factors influencing use, as well as novel insights into the experiences of and attitudes towards medicinal cannabis in people with epilepsy in the australian community. |
2018-01-16 |
2023-08-13 |
Not clear |
| Dustin Sulak, Russell Saneto, Bonni Goldstei. The current status of artisanal cannabis for the treatment of epilepsy in the United States. Epilepsy & behavior : E&B. vol 70. issue Pt B. 2018-01-16. PMID:28254350. |
the current status of artisanal cannabis for the treatment of epilepsy in the united states. |
2018-01-16 |
2023-08-13 |
Not clear |
| Dustin Sulak, Russell Saneto, Bonni Goldstei. The current status of artisanal cannabis for the treatment of epilepsy in the United States. Epilepsy & behavior : E&B. vol 70. issue Pt B. 2018-01-16. PMID:28254350. |
the widespread patient use of artisanal cannabis preparations has preceded quality validation of cannabis use for epilepsy. |
2018-01-16 |
2023-08-13 |
Not clear |
| Dustin Sulak, Russell Saneto, Bonni Goldstei. The current status of artisanal cannabis for the treatment of epilepsy in the United States. Epilepsy & behavior : E&B. vol 70. issue Pt B. 2018-01-16. PMID:28254350. |
neurologists and cannabinoid specialists are increasingly in a position to monitor and guide the use of herbal cannabis in epilepsy patients. |
2018-01-16 |
2023-08-13 |
Not clear |
| Dustin Sulak, Russell Saneto, Bonni Goldstei. The current status of artisanal cannabis for the treatment of epilepsy in the United States. Epilepsy & behavior : E&B. vol 70. issue Pt B. 2018-01-16. PMID:28254350. |
we report the retrospective data on efficacy and adverse effects of artisanal cannabis in patients with medically refractory epilepsy with mixed etiologies in washington state, california, and maine. |
2018-01-16 |
2023-08-13 |
Not clear |
| Silvia Koche. [Cannabis use in Epilepsy. Current situation in Argentina and abroad]. Vertex (Buenos Aires, Argentina). vol XXVII. issue 130. 2018-01-09. PMID:28898306. |
[cannabis use in epilepsy. |
2018-01-09 |
2023-08-13 |
human |
| Silvia Koche. [Cannabis use in Epilepsy. Current situation in Argentina and abroad]. Vertex (Buenos Aires, Argentina). vol XXVII. issue 130. 2018-01-09. PMID:28898306. |
preliminary data from human studies suggest that cannabis, cannabidiol in particular, is effective in the treatment of some patients with epilepsy. |
2018-01-09 |
2023-08-13 |
human |
| Silvia Koche. [Cannabis use in Epilepsy. Current situation in Argentina and abroad]. Vertex (Buenos Aires, Argentina). vol XXVII. issue 130. 2018-01-09. PMID:28898306. |
in order to perform these trials it is necessary to have legislation authorizing the use of cannabis on epilepsy. |
2018-01-09 |
2023-08-13 |
human |
| Michelle Neal. Efficacy and safety of cannabis for treating children with refractory epilepsy. Nursing children and young people. vol 29. issue 7. 2018-01-09. PMID:29115760. |
efficacy and safety of cannabis for treating children with refractory epilepsy. |
2018-01-09 |
2023-08-13 |
human |
| Michelle Neal. Efficacy and safety of cannabis for treating children with refractory epilepsy. Nursing children and young people. vol 29. issue 7. 2018-01-09. PMID:29115760. |
the aim of this literature review was to examine the evidence base for the safety and efficacy of cannabis in treating children with refractory epilepsy. |
2018-01-09 |
2023-08-13 |
human |